Validation of NASH-CHECK: a novel patient-reported outcome measure for nonalcoholic steatohepatitis
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource, 1 online resource.
- Sprache
-
Englisch
- Erschienen in
-
Validation of NASH-CHECK: a novel patient-reported outcome measure for nonalcoholic steatohepatitis ; volume:7 ; number:1 ; day:14 ; month:7 ; year:2023 ; pages:1-14 ; date:12.2023
Journal of patient-reported outcomes ; 7, Heft 1 (14.7.2023), 1-14, 12.2023
- Urheber
-
Twiss, James
Whalley, Diane
Doward, Lynda
Balp, Maria-Magdalena
Brass, Clifford A.
Cryer, Donna
Sanyal, Arun
Anstee, Quentin M.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s41687-023-00589-5
- URN
-
urn:nbn:de:101:1-2023101810555187440855
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:54 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Twiss, James
- Whalley, Diane
- Doward, Lynda
- Balp, Maria-Magdalena
- Brass, Clifford A.
- Cryer, Donna
- Sanyal, Arun
- Anstee, Quentin M.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Development of a Patient-Reported Outcome Measure for Non-Alcoholic Steatohepatitis (NASH-CHECK): Results of a Qualitative Study
A new method to induce nonalcoholic steatohepatitis (NASH) in mice
The burden of nonalcoholic steatohepatitis (NASH) in the United States
Plasma Pentraxin3 is a Novel Marker for Nonalcoholic Steatohepatitis (NASH)
Endoscopic duodenal mucosal resurfacing for nonalcoholic steatohepatitis (NASH): a pilot study
Nichtalkoholische Steatohepatitis (NASH) und alkoholische Steatohepatitis (ASH)
The role of mitochondrial genomics in patients with non-alcoholic steatohepatitis (NASH)
Deficiency of WTAP in hepatocytes induces lipoatrophy and non-alcoholic steatohepatitis (NASH)
Nichtalkoholische Fettleberhepatitis : = Nonalcoholic steatohepatitis
Die nichtalkoholische Steatohepatitis (NASH): Therapieansätze
Analysis of High-mobility Group A proteins in nonalcoholic steatohepatitis (NASH) and liver cancer
The role of Nrf2 and c-Met for the development of non-alcoholic steatohepatitis (NASH)
Development of a Patient-Reported Outcome Measure for Non-Alcoholic Steatohepatitis (NASH-CHECK): Results of a Qualitative Study
A new method to induce nonalcoholic steatohepatitis (NASH) in mice
The burden of nonalcoholic steatohepatitis (NASH) in the United States
Plasma Pentraxin3 is a Novel Marker for Nonalcoholic Steatohepatitis (NASH)
Endoscopic duodenal mucosal resurfacing for nonalcoholic steatohepatitis (NASH): a pilot study
Nichtalkoholische Steatohepatitis (NASH) und alkoholische Steatohepatitis (ASH)
The role of mitochondrial genomics in patients with non-alcoholic steatohepatitis (NASH)
Deficiency of WTAP in hepatocytes induces lipoatrophy and non-alcoholic steatohepatitis (NASH)
Nichtalkoholische Fettleberhepatitis : = Nonalcoholic steatohepatitis
Die nichtalkoholische Steatohepatitis (NASH): Therapieansätze
Analysis of High-mobility Group A proteins in nonalcoholic steatohepatitis (NASH) and liver cancer
The role of Nrf2 and c-Met for the development of non-alcoholic steatohepatitis (NASH)
Development of a Patient-Reported Outcome Measure for Non-Alcoholic Steatohepatitis (NASH-CHECK): Results of a Qualitative Study
A new method to induce nonalcoholic steatohepatitis (NASH) in mice
The burden of nonalcoholic steatohepatitis (NASH) in the United States
Plasma Pentraxin3 is a Novel Marker for Nonalcoholic Steatohepatitis (NASH)
Endoscopic duodenal mucosal resurfacing for nonalcoholic steatohepatitis (NASH): a pilot study
Nichtalkoholische Steatohepatitis (NASH) und alkoholische Steatohepatitis (ASH)
The role of mitochondrial genomics in patients with non-alcoholic steatohepatitis (NASH)
Deficiency of WTAP in hepatocytes induces lipoatrophy and non-alcoholic steatohepatitis (NASH)
Nichtalkoholische Fettleberhepatitis : = Nonalcoholic steatohepatitis
Die nichtalkoholische Steatohepatitis (NASH): Therapieansätze
Analysis of High-mobility Group A proteins in nonalcoholic steatohepatitis (NASH) and liver cancer